Impact of pharmacogenomics upon the therapeutic response to etanercept in psoriasis and psoriatic arthritis
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2017.1361404
Abstract: ABSTRACT Introduction: TNF-α inhibitors have demonstrated efficacy both as monotherapy and in combination with disease-modifying anti-rheumatic drugs (DMARDs) in the treatment of chronic inflammatory immune-mediated diseases. Etanercept is a decoy receptor” for TNF-α and it… read more here.
Keywords: pharmacogenomics upon; tnf; response; impact pharmacogenomics ... See more keywords